Nanobiotix SA Sponsored ADR NBTX 深 滬
等待開盤 05-14 09:30:00 美东时间
51.81
+3.570
+7.40%
華盛通- 最 高52.68
- 今 開49.90
- 成交量 3.97万股
- 最 低 48.51
- 昨 收 48.24
- 總市值 25.13亿
- 52周最高 54.7399
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 3.81
- 委 比 0.00%
- 總股本 4849.55万
- 歷史最高 54.7399
- 量 比 0.55
- 振 幅 8.64%
- 歷史最低 1.75
- 每 手 1
- 風險率 10.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nanobiotix Nanoprimer Pre-Treatment Demonstrates Reduced Hepatic Toxicity And Improved Systemic Bioavailability For LNP-DNA Cancer Immunotherapy In Preclinical Study
Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome common barriers faced by lipid nanoparticle("LNP")-delivered therapies related to rapid liver clearancePre-treatment with
04-20 15:49
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $26 to $36.
04-02 22:09
Nanobiotix shares are trading higher after the company reported a year-over-year decrease in FY25 loss per share.
Nanobiotix shares are trading higher after the company reported a year-over-yea...
04-01 22:43
Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate
Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 137.18 percent decrease over earnings of $1.56 per share from the same period last year. The company reported quarterly sales of $37.943
04-01 04:26
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
Nanobiotix Issues Statement Regarding Recent Media Speculation Concerning Intentions For A Potential Public Takeover; Says There Is No Such Intention To Acquire Control Of The Company, And No Process Or Assessment Is Being Conducted Toward That End
NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today issued the following
03-25 22:16
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday
U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-expected Q4 results and Benchmark upgrade.
03-13 21:59
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.
02-06 22:40
